Paulsen J E, Steffensen I L, Andreassen A, Vikse R, Alexander J
Department of Environmental Medicine, National Institute of Public Health, PO Box 4404 Torshov, N-0403 Oslo, Norway.
Carcinogenesis. 1999 Jul;20(7):1277-82. doi: 10.1093/carcin/20.7.1277.
We examined whether the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) could increase intestinal tumorigenesis in neonatal C57BL/6J-Min/+ mice, a murine model for familial adenomatous polyposis. Min/+ mice are heterozygous for a nonsense mutation in the adenomatous polyposis coli gene and spontaneously develop multiple intestinal adenomas, primarily in the small intestine. Neonatal Min/+ mice (3-6 days old) were exposed to PhIP via breast milk from lactating dams given 8 s.c. injections of 50 mg/kg PhIP three times a week or to 8 s.c. injections of 25 or 50 mg/kg PhIP directly, over the same period. At the age of 11 weeks, the number, diameter and location of the intestinal tumors were scored. Remarkably, a 2- to 4-fold increase in the number of small intestinal tumors was seen in Min/+ mice exposed to PhIP via breast milk (P < 0.001). To our knowledge, this is the first time PhIP has been reported to induce tumors following exposure via breast milk from PhIP-exposed dams. Upon direct exposure to 50 mg/kg PhIP, a 6- to 9-fold increase in the number of small intestinal tumors was observed (P < 0.001). The diameter of the PhIP-induced small intestinal tumors was slightly increased (P < 0.001). In the colon, a 3- to 4-fold increase in the number of tumors was seen in Min/+ mice exposed to PhIP via breast milk (P = 0. 004). Direct exposure to 50 mg/kg PhIP caused a 2- to 6-fold increase in the number of colonic tumors (P = 0.014). The PhIP-induced colonic tumors were located more distally and displayed a smaller diameter than the tumors from the controls (P < 0.05). In contrast to a previous study, where PhIP showed only a moderate tumorigenic effect in adult Min/+ mice, the present study demonstrates a strong tumorigenic effect of PhIP in neonatally exposed Min/+ mice, even after exposure via breast milk from PhIP-exposed dams.
我们研究了食品诱变剂2-氨基-1-甲基-6-苯基咪唑并[4,5-b]吡啶(PhIP)是否会增加新生C57BL/6J-Min/+小鼠的肠道肿瘤发生,这是一种家族性腺瘤性息肉病的小鼠模型。Min/+小鼠是腺瘤性息肉病大肠杆菌基因无义突变的杂合子,会自发形成多个肠道腺瘤,主要在小肠。新生Min/+小鼠(3至6日龄)通过每周3次皮下注射8次、每次50 mg/kg PhIP的哺乳期母鼠的母乳接触PhIP,或在同一时期直接皮下注射8次25或50 mg/kg PhIP。在11周龄时,对肠道肿瘤的数量、直径和位置进行评分。值得注意的是,通过母乳接触PhIP的Min/+小鼠小肠肿瘤数量增加了2至4倍(P < 0.001)。据我们所知,这是首次报道PhIP通过接触过PhIP的母鼠的母乳暴露后诱导肿瘤。直接接触50 mg/kg PhIP时,观察到小肠肿瘤数量增加了6至9倍(P < 0.001)。PhIP诱导的小肠肿瘤直径略有增加(P < 0.001)。在结肠中,通过母乳接触PhIP的Min/+小鼠肿瘤数量增加了3至4倍(P = 0. .004)。直接接触50 mg/kg PhIP导致结肠肿瘤数量增加了2至6倍(P = 0.014)。PhIP诱导的结肠肿瘤位于更远端,直径比对照组的肿瘤小(P < 0.05)。与之前一项研究不同,在该研究中PhIP在成年Min/+小鼠中仅显示出中等程度的致瘤作用,本研究表明PhIP在新生期暴露的Min/+小鼠中具有很强的致瘤作用,即使是通过接触过PhIP的母鼠的母乳暴露后也是如此。